The U.S. Court of Appeals for the Federal Circuit has affirmed a $3.5 million award in a patent infringement case involving the popular Wallet Ninja tool. The judgment sided with Dynamite Marketing in its lawsuit against WowLine Inc., leading to WowLine’s liability for damages and attorney fees. The Federal Circuit’s decision allows the jury’s previous…
In a significant legal determination, a federal jury in Texas has concluded that AT&T did not infringe upon a telecommunications patent held by Daingean Technologies Ltd. This verdict followed allegations from the Irish company that the telecom giant had violated its patent when implementing its 5G network services. Despite Daingean’s claims, the jury found insufficient…
Bose Corporation, the esteemed audio-engineering company known worldwide for its innovative technology, is seeking a declaratory judgment in a federal court. The company aims to counter accusations from a California-based firm alleging patent infringement on audio technology used in products like Bose’s QuietComfort headphones. This legal move is part of Bose’s broader strategy to defend…
The landscape of international litigation is evolving rapidly as several key trends emerge that demand the attention of global legal professionals. One emerging trend is the surge in intellectual property disputes involving Chinese manufacturers. In the past, many Western companies accused Chinese firms of infringing on their patents and trademarks; however, the dynamics are shifting….
The appointment of a new Director for the U.S. Patent and Trademark Office (USPTO) has stirred debate on Capitol Hill, where a former USPTO solicitor recently emphasized the urgency of confirming John Squires for the position. This exhortation underscores a rising concern: ensuring political accountability is now perceived as a key priority even if it…
The U.S. Senate has been urged to confirm John Squires as the new director of the U.S. Patent and Trademark Office (USPTO), despite ongoing debates over ideal leadership qualities for the position. A former USPTO solicitor emphasized the need for political accountability, suggesting that having someone in the role is more crucial than waiting for…
The Patent Trial and Appeal Board (PTAB) has initiated a review of a patent related to Nike Inc.’s Flyknit line of sneakers. This decision comes after a remand by the acting head of the U.S. Patent and Trademark Office, who revived Skechers’ challenge to the patent. The dispute highlights the ongoing complexity and competitiveness in…
Reissue applications, though representing a small fraction of the total number of applications filed at the U.S. Patent and Trademark Office annually, offer critical strategic opportunities for patent holders. Their use can be instrumental in refining a patent’s scope or correcting errors, thereby enhancing its enforceability and value. The primary advantage of utilizing reissue applications…
Under Armour has secured a significant legal victory through the Patent Trial and Appeal Board (PTAB), which has invalidated numerous claims from four patents, all owned by a company specializing in golf shoes. This decision plays a critical role as Under Armour faces ongoing litigation in a Texas federal court over the same patents. The…
A California federal jury has awarded Carl Zeiss X-Ray Microscopy Inc. $785,000 in damages after determining that Sigray Inc. infringed on Zeiss’s X-ray imaging patents. The jury concluded that Sigray’s infringement was not willful and declined to award any lost profits. This verdict is the latest development in a protracted legal battle between the two…
The Federal Circuit recently declined a request by a group of cherry growers to reinstate a court order invalidating a patent for the Staccato cherry variety, which is owned by the Canadian government. This decision confirms that the district judge’s actions in overturning the previous order were appropriate. The case revolves around the validity of…
The Federal Circuit recently issued a decision maintaining the venue for a pair of patent infringement cases against technology giants Google and Amazon in California, rather than returning them to Texas. This affirmation aligns with previous findings that California presents a more suitable venue for the cases. These decisions often hinge on various jurisdictional factors,…
The rapid evolution of artificial intelligence technologies has triggered a significant uptick in appellate litigation, centered around three pivotal decisions by the U.S. Supreme Court. This surge is shaping the legal landscape and prompting both corporate legal teams and law firms to reassess their strategies. The convergence of AI and the judicial system is becoming…
The Federal Circuit’s recent decision to uphold its previous rulings in several intellectual property cases has further entrenched key precedents in patent and trademark law. Notably, one of the cases involved Acadia Pharmaceuticals and its Parkinson’s disease drug patent. The core issue in this case was double-patenting, a legal doctrine aimed at preventing patent holders…
Broadcom Corporation has petitioned the U.S. Court of Appeals for the Federal Circuit to overturn a California federal judge’s decision that invalidated two of its data patents asserted against Netflix. The company contends that the judge erred in determining that the patents covered processes that could be performed by a traffic officer or a 19th-century…
In a recent decision issued on July 8, the U.S. Court of Appeals for the Federal Circuit upheld a significant ruling in the case of Janssen Pharmaceuticals Inc. et al. v. Teva Pharmaceuticals USA Inc. This ruling affirmed the U.S. District Court for the District of New Jersey’s conclusion that the patent claims concerning the…
In a recent development, over three dozen conservative groups have voiced concerns to the U.S. Department of Commerce regarding a proposed policy that could impose a value-based tax on patents. These organizations caution that such a measure, described as a “patent tax,” could significantly stifle innovation throughout the United States, particularly impacting sectors involved with…
In a recent legal controversy that has captured the attention of pharmaceutical and legal professionals alike, CVS Pharmacy Inc. has filed a lawsuit in California federal court against Takeda Pharmaceutical Co. Ltd. This legal action accuses Takeda, along with other associated entities, of participating in what is described as a “horizontal conspiracy and agreement” to…
U.S. Secretary of Commerce Howard W. Lutnick has announced the appointment of two notable legal professionals to the public advisory committees of the U.S. Patent and Trademark Office (USPTO), a decision made six months after previous members were removed. These appointments aim to bolster the advisory capabilities of the USPTO with individuals who have extensive…
The acting chief judge of the Patent Trial and Appeal Board (PTAB) recently emphasized the need for litigants to provide detailed arguments when engaging with the board’s discretionary denial process. This assertion came during a panel discussion where the judge highlighted the importance of specificity in supporting arguments to enhance the clarity and effectiveness of…
Meta Platforms Inc. is once again in the legal spotlight, having been hit with a patent infringement lawsuit in a Texas federal court. The lawsuit alleges that Meta has infringed upon two patents related to search engine technology, specifically aimed at ranking online content based on user engagement. These innovations are pivotal in determining how…
The U.S. Court of Appeals for the Federal Circuit has overturned a decision by U.S. District Judge Alan Albright, who had denied Realtek Semiconductor Corp.’s request for attorneys’ fees following the dismissal of a patent infringement lawsuit against the company. The appellate court determined that Realtek qualifies as the prevailing party, even though the plaintiff…
Sandoz Inc. and Regeneron Pharmaceuticals Inc. have reached a settlement concerning the patent claims that Regeneron had asserted over Sandoz’s proposed biosimilar to Eylea, Regeneron’s treatment for ophthalmic disorders. This resolution comes as a significant development in the ongoing battles over biosimilar drugs, which are designed to be nearly identical to already approved biologic medicines….
In a significant development in the realm of fleet management technology, the U.S. International Trade Commission (ITC) has made a pivotal ruling regarding a patent infringement case. An ITC judge has decided in favor of the startup Motive Technologies Inc., dismissing claims brought against it by a competitor that specializes in tracking technology for the…
In a strategic move, U.S. Secretary of Commerce Howard W. Lutnick has appointed a new set of distinguished individuals to the United States Patent and Trademark Office’s (USPTO) public advisory committees. This development occurs nearly six months after the previous committee members were removed, signaling a fresh start aimed at fortifying the institution’s strategic outlook….